SCHEMBL10478366

SCHEMBL10478366

CCN(CC)c1ccccc1C[S+]([O-])c1nc2cscc2[nH]1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10478304 0.88 ATP4A (0.38) AR
SCHEMBL9398029 0.86 LMNA (0.48) LMNACYP1A2CYP2D6CYP2C19AR
SCHEMBL10702277 0.81 ATP4A (0.35)
SCHEMBL10698917 0.80 LMNA (0.34) LMNACYP1A2CYP2D6CYP2C19AR
SCHEMBL10478422 0.80 ATP4A (0.34)
SCHEMBL9676077 0.80 LMNA (0.44) LMNACYP1A2CYP2D6CYP2C19
SCHEMBL9395776 0.79 RAB9A (0.46) LMNACYP1A2CYP2D6CYP2C19
SCHEMBL9395764 0.78 ALDH1A1 (0.38) LMNACYP1A2CYP2D6CYP2C19
SCHEMBL10698492 0.78 LMNA (0.36) LMNAAR
SCHEMBL9695897 0.77 PDE5A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4871734-A ANTISECRETORY AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-10-03 US claimed
EP-0271733-A2 Substituted thienoimidazotoluidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use as gastric-acid secretion inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1988-06-22 EP claimed
US-4871734-A ANTISECRETORY AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-10-03 US disclosed
EP-0271733-A2 Substituted thienoimidazotoluidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use as gastric-acid secretion inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1988-06-22 EP disclosed